Skip to content

Clinical trials

Observational Hyperphosphatemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperphosphatemia Phase: Observational Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20094
20102
20111
20121
20132
20161
20181
20203
20221
20234
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status5
Recruiting2
Terminated2
Withdrawn1
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Shire2
Assistance Publique - Hôpitaux de Paris1
Assiut University1
Astellas Pharma Inc1
Duke University1
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore1
Fresenius Medical Care Deutschland GmbH1
Genzyme, a Sanofi Company1
Great Ormond Street Hospital for Children NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperphosphatemia24
Renal Insufficiency, Chronic5
Chronic Kidney Disease-Mineral and Bone Disorder3
Kidney Failure, Chronic3
Heart Failure2
Hypophosphatemia2
Adrenal Insufficiency1
Arrhythmias, Cardiac1
Arteriovenous Fistula1
Attention Deficit Disorder with Hyperactivity1

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.